Thrivent Financial for Lutherans Decreases Stock Holdings in HealthEquity, Inc. $HQY

Thrivent Financial for Lutherans lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 17.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 282,442 shares of the company’s stock after selling 57,895 shares during the period. Thrivent Financial for Lutherans’ holdings in HealthEquity were worth $29,588,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its position in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in HealthEquity in the second quarter valued at approximately $33,000. WPG Advisers LLC purchased a new stake in shares of HealthEquity during the first quarter valued at approximately $28,000. Cullen Frost Bankers Inc. lifted its position in shares of HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after purchasing an additional 224 shares in the last quarter. Finally, Sellwood Investment Partners LLC purchased a new position in shares of HealthEquity in the second quarter valued at $58,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on HQY. Barrington Research reaffirmed an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. KeyCorp dropped their target price on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. BTIG Research reiterated a “buy” rating and issued a $130.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 price target on shares of HealthEquity in a report on Friday, December 5th. Finally, Citizens Jmp lifted their price objective on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus price target of $120.27.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $95.75 on Tuesday. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.18 billion, a price-to-earnings ratio of 43.92, a price-to-earnings-growth ratio of 1.40 and a beta of 0.18. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The business has a 50 day simple moving average of $96.86 and a 200-day simple moving average of $96.59.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. During the same quarter in the previous year, the company posted $0.78 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Thursday, November 20th. The stock was sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the transaction, the executive vice president directly owned 75,479 shares in the company, valued at $7,892,084.24. This represents a 1.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 10,781 shares of company stock valued at $1,016,707. Insiders own 1.50% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.